Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal leishmaniasis in Brazil.

J T Zajtchuk1, J D Casler, E M Netto

  • 1Otolaryngology/Head and Neck Surgery Service, Walter Reed Army Medical Center, Washington, DC 20307-5001.

The Laryngoscope
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic adverse events from inhaled corticosteroids self-reported by asthma patients: A "real-life" cross sectional study.

Revista portuguesa de pneumologia·2016
Same author

Dual-Acquisition Extracranial Computed Tomographic Angiography-Enhanced Neck Computed Tomography before Transoral Laser Microsurgery in Head and Neck Cancer Patients. Preliminary results.

The neuroradiology journal·2013
Same author

Travelers with cutaneous leishmaniasis cured without systemic therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2013
Same author

Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2011
Same author

Reference range for T lymphocytes populations in blood donors from two different regions in Brazil.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2010
Same author

Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis.

Parasite immunology·2009

Diagnosing mucosal leishmaniasis caused by Leishmania braziliensis braziliensis is challenging. An immunofluorescent antibody technique proved superior to histopathology for detecting parasites in patient biopsies.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Tropical Medicine

Background:

  • Mucosal leishmaniasis caused by Leishmania braziliensis braziliensis presents diagnostic difficulties.
  • Accurate identification of Leishmania parasites in affected tissues is crucial for effective treatment.

Purpose of the Study:

  • To compare the efficacy of an indirect immunofluorescent assay (IFA) with routine histopathology for detecting Leishmania amastigotes in mucosal biopsies.
  • To evaluate treatment outcomes for mucosal leishmaniasis in endemic areas of Brazil.

Main Methods:

  • Retrospective analysis of 58 patients with mucosal leishmaniasis in Bahia, Brazil.
  • Biopsies were examined using hematoxylin and eosin histopathology and a genus-specific indirect immunofluorescent assay.
  • Treatment efficacy was assessed based on relapse rates following low-dose (10 mg/kg) versus high-dose (20 mg/kg) meglumine antimoniate therapy.

Related Experiment Videos

Main Results:

  • The immunofluorescent assay detected Leishmania amastigotes in 7 of 14 clinically active mucosal disease cases, while histopathology did not identify parasites in inactive cases.
  • The IFA was significantly more sensitive than histopathology for detecting intracellular amastigotes in mucosal biopsy sections.
  • Relapse rates were 31% for low-dose and 27.3% for high-dose meglumine antimoniate, with no statistically significant difference between the groups.

Conclusions:

  • The indirect immunofluorescent assay is a superior diagnostic tool for identifying Leishmania amastigotes in mucosal biopsies compared to traditional histopathology.
  • Both low and high doses of meglumine antimoniate showed similar relapse rates in treating mucosal leishmaniasis.
  • Further research into optimal treatment regimens for this parasitic disease is warranted.